Reliance Industries Reports the Acquisition of Karkinos Healthcare for ~$43.88M
Shots:
- Reliance Industries, through its subsidiary Reliance Strategic Business Ventures (RSBVL), has acquired Karkinos Healthcare for ~$43.88M (INR 375 Cr)
- The acquisition aims to expand Reliance's health services portfolio, enhancing its presence in the healthcare sector
- Karkinos is a tech-based healthcare platform that specializes in early cancer detection, diagnosis, treatment & management. It has collaborated with 60 hospitals (as of Dec 2023) to offer these services plus will set up a 150-bed cancer hospital in Imphal, Manipur
Ref: Times of India | Image: Karkinos Healthcare
Related News:- AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
